Community Research and Development Information Service - CORDIS

Commercial feasibility study of a technology that multiplies blood stem cells to increase the success of transplants for cancer treatment

From 2016-06-01 to 2016-09-30, closed project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

Portugal

Call for proposal:

H2020-SMEINST-1-2016-2017See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Coordinator

GROWINGFORMULA LDA
Portugal

EU contribution: EUR 50 000


BIOCANT PARK NUCLEO 04, LOTE 02
3060 197 CANTANHEDE
Portugal
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top